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Background
Hepatocellular carcinoma (HCC) represents >90% of pri-
mary liver neoplasms and develops mainly in patients
with liver cirrhosis. Risk factor identification for develop-
ment of HCC in patients with cirrhosis possesses great
clinical relevance due to its high incidence and poor prog-
nosis when detected at advanced stages. The aim of our
study was to identify HCC development-associated risk
factors in a cohort of patients with hepatitis virus-related
chronic liver disease and cirrhosis.
Materials and methods
Patients with a diagnosis of hepatitis virus-related cirrho-
sis from January 1980 to January 2000 were included.
Patients were followed with abdominal ultrasound and
determination of alpha-fetoprotein levels, physical exam-
ination, and routine biochemical tests every 3–6 months.
The endpoint in this study was defined as development of
HCC. Liver histology was evaluated according to the
French METAVIR Cooperative Study Group (METAVIR)
score.
Results
Two hundred and eighty two patients met the inclusion
criteria; the majority of these (86%) had a serologic diag-
nosis of hepatitis C virus, and only 14% had hepatitis B
virus at the time of diagnosis of cirrhosis, while 56 and
37% were classified as Child A and B, respectively, and
only 7% as Child C. Histological activity was mild in 59%
of patients, and moderate and severe in 41%. Mean
annual incidence was 1.87%, and 22 and 35% of patients
developed HCC at 10 and 15 years of follow-up, respec-
tively. Diagnosis of HCC was made by histopathology in
37% and by tumoral lesion-associated alpha-fetoprotein
elevation confirmed by imaging studies in 63%. In multi-
variate analysis, we found three variables associated with
HCC: moderate to severe histological activity; platelet
count <105 × 103/mm3, and alpha-fetoprotein >5 ng/mL
(see Table 1). We divided patients into two groups accord-
ing to regression coefficient: low and high-risk; patients
assigned to the low-risk group showed 5-, 10-, and 15-year
HCC incidences of 3.4, 6.4, and 6.4%, respectively, in
contrast to patients from the high-risk group, who showed
incidences of 17.8, 33.5, and 56.8%, respectively.
Conclusion
We found three HCC-associated variables: histological
activity; platelet count and alpha-fetoprotein levels.
Patients with high risk for developing hepatocellular car-
cinoma must be considered candidates for closer follow-
up.
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Table 1: Variables with independent predictive value for HCC in the multivariate analysis
Variables Hazard ratio (95% confidence interval) Coefficients P value (log rank)
Platelet count 3.7 (1.2–11) 1.3 0.025
α-fetoprotein 5.41 (1.86–15.7) 1.23 0.02
Histological activity 7.6 (1.7–33) 2.03 0.007